A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy

Clinical trial NCT00447421 · TERMINATED

Trial details

NCT number: NCT00447421
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer Carcinoma, Small Cell SCLC

Start date: 2007-02-01
Primary completion: 2008-05-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.